Brain Organoids for Drug Screening
Research Tool / Drug Discovery
Pre-clinicalActive
Key Facts
About Eureka Biotechnology
Eureka Biotech, founded in 2015 and headquartered in Philadelphia, Pennsylvania, is a private, pre-revenue biotech firm specializing in induced pluripotent stem cell (iPSC) and organoid platforms. Its core activities include developing disease-specific iPSCs, brain and heart organoids for drug screening, and artificial skin models, with a secondary initiative in cultured meat production. The company operates as a subsidiary of the Eureka International Group and is strategically positioned near major academic institutions to facilitate research and collaboration.
View full company profileTherapeutic Areas
Other Research Tool / Drug Discovery Drugs
| Drug | Company | Phase |
|---|---|---|
| RNA Structure Change Sensors | Lucerna | Development |
| Heart Organoids for Drug Screening | Eureka Biotechnology | Pre-clinical |